Strategies to Prevent Manufacture and Distribution of Substandard Medications
Register for this event
- DateTue 08 October 2019
- Time10:00 AM - 11:30 AM
- Location39658 Mission Boulevard, Fremont National 9453
- Ticket$$150 per person
- Table$Price for a table per table (seats Normally between 8-12)
- ContactNetzealous LLC DBA - Compliance4all
Substandard product can exist even if the product itself is manufactured according to quality standards. Muhammad H. Zaman, in his book Bitter Pills, recalls his visit to a warehouse in Ghana that had no climate control, with temperatures in the warehouse reaching 95 degrees Fahrenheit.
Recently, Allergan's Taytulla birth control products were recalled due to the packaging of active tablets and inert tablets in the wrong order, potentially leading to patients likewise taking the tablets in the wrong order and not obtaining the desired result. Allergan stated, "As a result of this packaging error, oral contraceptive capsules that are taken out of sequence may place the user at risk for contraceptive failure and unintended pregnancy."
Harm to patients and damage to a company's reputation are the two most obvious consequences of substandard product. Yet, many companies pay too little attention to these problems, preferring short-term gain over long-term reputation and profitability. Within companies, it is common to hear the argument that quality is a cost center and does not directly contribute to the company's profits.